Skip to main content

eVestment's Top Hedge Funds In May

Our monthly gaze into the activities of eVestment's investor and consultant subscriber base sees Canyon Capital's Value Realization Master Fund take home the gong in May for the most viewed hedge fund in eVestment's universe of products. AQR's Style Premia came in second, and 1060 Capital Management's Opportunity Fund came third.

eVestment

At the firm level, Blackrock took home the honours. It's Appreciation Strategy Fund was BLK's most viewed product by eVestment users, with AQR coming second and Indus Capital Partners in third.

eVestment

At the strategy level, fundamental long/short equity unsurprisingly came out on top - again - for the fifth consecutive month. Multi-strategy and fund of funds rounded out the top 3.

eVestment

Indus Capital's appearance in third place on the list of most viewed firms this month was no surprise given that it was the highest mover vs. the past 6 months of activity. Blackrock came in second but whilst its Appreciation Strategy Fund was the most viewed product in May, the firm's biggest riser over the last six months was its Global Alpha Opportunities Fund. Hedge Invest's HI Principia Fund came third.

eVestment

Zeal Asset Management came in seventh in the list of rising firms but its Zeal China Fund was the single largest riser in May vs. the average of the prior 6 months. Rising firm Indus Capital had 2 funds on the top 10; it's Japan fund and its Asia Pacific Fund.

eVestment

Be sure to tune in next month for the next installment and, as ever, if any readers represent firms on these lists and you get an allocation, drop us a line!

© The Sortino Group Ltd

All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or scanning or otherwise, except under the terms of the Copyright, Designs and Patents Act 1988 or under the terms of a licence issued by the Copyright Licensing Agency or other Reprographic Rights Organisation, without the written permission of the publisher. For more information about reprints from AlphaWeek, click here.